Max Fink

1.1k total citations
14 papers, 699 citations indexed

About

Max Fink is a scholar working on Pharmacology, Psychiatry and Mental health and Clinical Psychology. According to data from OpenAlex, Max Fink has authored 14 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 4 papers in Psychiatry and Mental health and 3 papers in Clinical Psychology. Recurrent topics in Max Fink's work include Electroconvulsive Therapy Studies (4 papers), Treatment of Major Depression (3 papers) and Psychotherapy Techniques and Applications (2 papers). Max Fink is often cited by papers focused on Electroconvulsive Therapy Studies (4 papers), Treatment of Major Depression (3 papers) and Psychotherapy Techniques and Applications (2 papers). Max Fink collaborates with scholars based in United States and Myanmar. Max Fink's co-authors include Garth Bissette, Huda Akil, Charles B. Nemeroff, Donald F. Klein, John C. Kramer, Georgios Petrides, Andrew Francis, Dirk M. Dhossche, Rhea Dornbush and Alfred M. Freedman and has published in prestigious journals such as American Journal of Psychiatry, The British Journal of Psychiatry and Neuropsychobiology.

In The Last Decade

Max Fink

12 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Max Fink United States 10 359 271 150 111 88 14 699
Greden Jf United States 10 200 0.6× 188 0.7× 152 1.0× 137 1.2× 36 0.4× 17 526
Fran Van Hunsel Belgium 12 254 0.7× 149 0.5× 199 1.3× 155 1.4× 100 1.1× 12 669
A F Schatzberg United States 12 285 0.8× 176 0.6× 126 0.8× 149 1.3× 75 0.9× 15 625
G Charles Belgium 14 180 0.5× 184 0.7× 229 1.5× 153 1.4× 58 0.7× 41 721
C R Lake United States 14 189 0.5× 99 0.4× 163 1.1× 85 0.8× 193 2.2× 30 905
Norma L. Pearson United States 3 282 0.8× 443 1.6× 47 0.3× 166 1.5× 46 0.5× 5 776
A. Ariav Albala United States 10 173 0.5× 140 0.5× 168 1.1× 103 0.9× 78 0.9× 15 585
Cohen Rm United States 12 242 0.7× 168 0.6× 68 0.5× 49 0.4× 169 1.9× 26 616
Jeffrey Apter United States 11 245 0.7× 331 1.2× 84 0.6× 74 0.7× 240 2.7× 18 806
Adelheid Czernik Germany 11 411 1.1× 97 0.4× 136 0.9× 89 0.8× 103 1.2× 30 747

Countries citing papers authored by Max Fink

Since Specialization
Citations

This map shows the geographic impact of Max Fink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Fink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Fink more than expected).

Fields of papers citing papers by Max Fink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Fink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Fink. The network helps show where Max Fink may publish in the future.

Co-authorship network of co-authors of Max Fink

This figure shows the co-authorship network connecting the top 25 collaborators of Max Fink. A scholar is included among the top collaborators of Max Fink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Fink. Max Fink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Fink, Max, et al.. (2001). Akupunktur als komplementäres Behandlungsverfahren in der Physikalischen Medizin am Beispiel der Koxarthrose. Physikalische Medizin Rehabilitationsmedizin Kurortmedizin. 11(4). 123–128. 1 indexed citations
2.
Fink, Max. (1994). Marihuana, the Forbidden Medicine. American Journal of Psychiatry. 151(7). 1091–1091. 52 indexed citations
3.
Petrides, Georgios, Dirk M. Dhossche, Max Fink, & Andrew Francis. (1994). Continuation ECT: relapse prevention in affective disorders.. PubMed. 10(3). 189–94. 45 indexed citations
4.
Nemeroff, Charles B., Garth Bissette, Huda Akil, & Max Fink. (1991). Neuropeptide Concentrations in the Cerebrospinal Fluid of Depressed Patients Treated with Electroconvulsive Therapy. The British Journal of Psychiatry. 158(1). 59–63. 201 indexed citations
5.
Fink, Max. (1990). Epilepsy, Behaviour and Cognitive Function. American Journal of Psychiatry. 147(5). 665–b. 9 indexed citations
6.
Fink, Max. (1984). Pharmacoelectroencephalography:A Note on Its History. Neuropsychobiology. 12(2-3). 173–178. 16 indexed citations
7.
Fink, Max. (1979). Convulsive therapy : theory and practice. Medical Entomology and Zoology. 238 indexed citations
8.
Dornbush, Rhea, Alfred M. Freedman, & Max Fink. (1976). Chronic cannabis use. New York Academy of Sciences eBooks. 10 indexed citations
9.
Fink, Max. (1976). Safeguarding Psychiatric Privacy: Computer Systems and Their Uses. American Journal of Psychiatry. 133(6). 726–a. 22 indexed citations
10.
Fink, Max, et al.. (1972). Answers to questions frequently asked about ECT.. PubMed. 4(1). 33–8. 5 indexed citations
11.
Spero, Moshe Halevi, et al.. (1970). A comparison of doxepin and chlordiazepoxide in the therapy of anxiety.. PubMed. 12(4). 201–12. 9 indexed citations
12.
Fink, Max, et al.. (1962). The Disposition of Applications for Psychotherapy in an Out-Patient Clinic. Social Casework. 43(10). 545–547. 2 indexed citations
13.
Kramer, John C., Donald F. Klein, & Max Fink. (1961). WITHDRAWAL SYMPTOMS FOLLOWING DISCONTINUATION OF IMIPRAMINE THERAPY. American Journal of Psychiatry. 118(6). 549–550. 88 indexed citations
14.
Fink, Max, et al.. (1953). Effect of intravenous barbiturate on perception.. PubMed. 3(78th Meeting). 244–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Greden Jf Breakdown of academic impact, for papers by Fran Van Hunsel Breakdown of academic impact, for papers by A F Schatzberg Breakdown of academic impact, for papers by G Charles Breakdown of academic impact, for papers by C R Lake Breakdown of academic impact, for papers by Norma L. Pearson Breakdown of academic impact, for papers by A. Ariav Albala Breakdown of academic impact, for papers by Cohen Rm Breakdown of academic impact, for papers by Jeffrey Apter Breakdown of academic impact, for papers by Adelheid Czernik
Rankless by CCL
2026